Position in RXRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,404,537
-$73,482 QoQ
Shares Held
457,504
+26.6% QoQ
Ownership
0.086%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ALLIANCEBERNSTEIN L.P. holds $5,113,566,936 across 211 Biotechnology names. RXRX ranks #99 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,910,786 | $1,746,322,380 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
426,914 | $329,850,832 | |
| 3 | ARGX |
Argenx SE
|
422,304 | $308,387,496 | |
| 4 | GMAB |
Genmab A/S
|
9,557,149 | $256,418,307 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
1,908,907 | $141,755,433 | |
| 6 | TECH |
BIO-TECHNE Corp
|
2,213,197 | $115,661,675 | |
| 7 | INSM |
INSMED Inc
|
688,734 | $112,621,783 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
1,736,501 | $112,230,059 |
All Filings in RXRX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,404,537 | 457,504 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,478,019 | 361,374 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,765,984 | 361,882 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,828,552 | 361,374 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,335,799 | 252,514 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,644,126 | 243,214 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,431,967 | 217,294 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,629,705 | 217,294 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,436,118 | 144,044 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $2,079,631 | 210,916 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,247,883 | 163,122 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,305,705 | 308,662 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $2,058,775 | 308,662 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,011,564 | 390,605 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $34,445,340 | 3,237,344 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $29,311,814 | 3,600,960 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $24,205,940 | 3,380,718 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $49,262,779 | 2,875,819 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $37,721,236 | 1,639,341 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $47,447,153 | 1,299,922 | Shares | Defined | 2021-07-30 | |
| No filing history on record for this holder in this stock. | ||||||